Table 2.
SP (% volume) | LADSP (% volume) | P value | ||
---|---|---|---|---|
CTVbreast | 90% isodose coverage | 99.37 | 99.07 | 0.0032 |
95% isodose coverage | 97.61 | 97.22 | 0.0005 | |
100% isodose coverage | 84.32 | 83.56 | 0.0001 | |
CTVboost | 90% isodose coverage | 99.97 | 99.97 | 0.3223 |
95% isodose coverage | 99.34 | 99.32 | 0.4890 | |
100% isodose coverage | 59.13 | 59.13 | 0.9851 | |
Dmax (Gy) | 61.89 | 61.93 | 0.0753 | |
PTVbreast Eval | 90% isodose coverage | 98.7 | 97.69 | <0.0001 |
95% isodose coverage | 95.91 | 94.58 | <0.0001 | |
100% isodose coverage | 79.1 | 77.41 | <0.0001 | |
PTVboost Eval | 90% isodose coverage | 99.85 | 99.82 | 0.0952 |
95% isodose coverage | 95.56 | 95.26 | 0.0096 | |
100% isodose coverage | 43.46 | 43.27 | 0.4308 | |
Dmax (Gy) | 61.96 | 61.98 | 0.0441 |
SP, standard plan; LADSP, left anterior descending coronary artery – shielded plan; CTV, clinical target volume; PTV, planning target volume.